In SEC Filing Ackman Says Allergan is "Sandbagging"Mark Melin
William Ackman’s Pershing Square recently filed a Securities and Exchange Commission 14A form regarding statements he made about Allergan, Inc. (NYSE:AGN) in his recent investor letter.
Ackman praises his buddy Bill Johnson for working with a cancer research firm
The SEC’s 14A form is typically used to provide shareholders information to make “informed” votes at shareholder meetings. Ackman starts exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible